Svetlana Ni Makhni

Svetlana Ni Makhni has a strong background in finance and has held various roles throughout their career. Svetlana Ni currently serves as the Chief Financial Officer at Marengo Therapeutics since June 2022. Prior to that, they were the Chief Financial Officer at Escient Pharmaceuticals from May 2021 to June 2022. From October 2019 to May 2021, they worked as the CFO and Head of Operations at Bierman ABA. Earlier in their career, they worked as a Director at BMO Capital Markets from June 2015 to October 2019. Svetlana Ni also served as an Associate at Goldman Sachs from July 2012 to March 2014. Before that, they held positions at Westbrook Partners, where they worked as a Vice President from April 2007 to June 2010, and at The Blackstone Group, where they worked as an Analyst from July 2006 to April 2007.

Svetlana Ni Makhni's education history includes a Bachelor of Science degree in Finance and Accounting from The Wharton School. Additionally, they attended Harvard Business School to pursue their Master of Business Administration degree. However, specific start and end years for both educational experiences are not provided.